Skip to main content
Therapy-induced malignant neoplasms in Nf1 mutant mice.
JAKing up hematopoietic proliferation.
Focus on myeloproliferative diseases and myelodysplastic syndromes.
The sum is greater than the FGFR1 partner.
Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells.
Acute leukemia: a pediatric perspective.
Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis.
Resistance in the land of molecular cancer therapeutics.